Regeneron Pharmaceuticals logo
Regeneron Pharmaceuticals REGN
$ 753.08 0.48%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Regeneron Pharmaceuticals EV/EBITDA Ratio 2011-2024 | REGN

Annual EV/EBITDA Ratio Regeneron Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
7.63 13.9 14.5 16.3 17.8 24.8 32 46.5 35.5 33.6 -45.1

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
46.5 -45.1 18